Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst maintained a Buy rating on CSPC Pharmaceutical Group on July 27 and set a price target of HK$11.00. The company’s shares closed last Friday at HK$8.30.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks CSPC Pharmaceutical Group has an analyst consensus of Moderate Buy, with a price target consensus of HK$11.84.
Morgan Stanley analyst maintained a Buy rating on CSPC Pharmaceutical Group on July 27 and set a price target of HK$11.00. The company’s shares closed last Friday at HK$8.30.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
CSPC Pharmaceutical Group has an analyst consensus of Moderate Buy, with a price target consensus of HK$11.84.